Highline Wealth Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Buy
297
+43
+17% +$13.1K 0.03% 145
2026
Q1
$54.3K Buy
254
+77
+44% +$17.2K 0.01% 171
2025
Q4
$30.3K Buy
177
+35
+25% +$5.44K 0.01% 190
2025
Q3
$19K Sell
142
-530
-79% -$56.1K 0.01% 284
2025
Q2
$65.4K Sell
672
-12
-2% -$952 0.02% 131
2025
Q1
$49.7K Buy
684
+8
+1% +$630 0.02% 134
2024
Q4
$48.8K Sell
676
-14
-2% -$1.06K 0.02% 131
2024
Q3
$56.3K Buy
690
+670
+3,350% +$58.3K 0.02% 126
2024
Q2
$2.13K Hold
20
﹤0.01% 387
2024
Q1
$1.94K Hold
20
﹤0.01% 332
2023
Q4
$1.57K Hold
20
﹤0.01% 316
2023
Q3
$1.25K Hold
20
﹤0.01% 302
2023
Q2
$1.29K Hold
20
﹤0.01% 254
2023
Q1
$1.06K Hold
20
﹤0.01% 266
2022
Q4
$841 Hold
20
﹤0.01% 271
2022
Q3
$732 Buy
+20
New +$890 ﹤0.01% 275

Other funds holding LRCX

Highline Wealth Partners's LRCX Position: Q2 2026 in Review

Highline Wealth Partners increased its Lam Research (LRCX) stake by 17% in Q2 2026, buying an estimated $13.1K and bringing the position to 297 shares worth $129K. The position accounts for 0.03% of the portfolio, ranked #145.

Highline Wealth Partners first reported a position in LRCX in Q3 2022 and has held it in 16 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Highline Wealth Partners held 297 shares of Lam Research worth $129K as of Q2 2026.
  • Highline Wealth Partners bought 43 Lam Research shares in Q2 2026, an estimated $13.1K.
  • Lam Research made up 0.03% of Highline Wealth Partners's portfolio in Q2 2026, its #145 holding.
  • Highline Wealth Partners first reported a position in Lam Research in Q3 2022 and has held it in 16 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.